Deprescribing Trials: Methods to Reduce Polypharmacy and the Impact on Prescribing and Clinical Outcomes

Clinics in Geriatric Medicine

Volumn 28, Issue 2, 2012, Pages 237-253

  Gnjidic, Danijela ^a,b,c   Le Couteur, David G ^b,c,d   Kouladjian, Lisa ^a   Hilmer, Sarah N ^a,b  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Department of Microbiology and Infectious Diseases   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Effectiveness of interventions; Medication withdrawal; Medications; Older adults; Polypharmacy

Indexed keywords

PSYCHOTROPIC AGENT;

COGNITION; COMORBIDITY; DAILY LIFE ACTIVITY; DEPRESSION; DRUG EXPOSURE; EVIDENCE BASED PRACTICE; HEALTH CARE ACCESS; HEALTH SERVICE; HEALTH STATUS; HUMAN; MORBIDITY; MORTALITY; PATIENT COMPLIANCE; PHARMACIST; POLYPHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; REVIEW; RISK FACTOR;

ADULT; AGED; CLINICAL TRIALS AS TOPIC; DRUG PRESCRIPTIONS; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PHARMACEUTICAL PREPARATIONS; PHARMACISTS; PHYSICIANS; POLYPHARMACY; RISK FACTORS;

EID: 84859706610     PISSN: 07490690     EISSN: 18798853     Source Type: Journal    
DOI: 10.1016/j.cger.2012.01.006     Document Type: Review

References (60)

1. Van Spall H.G., Toren A., Kiss A., et al. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 2007, 297:1233-1240.
2. Hilmer S.N., Gnjidic D., Abernethy D.R. Pharmacoepidemiology in the postmarketing assessment of the efficacy and safety of drugs in older people. J Gerontol A Biol Sci Med Sci 2012, 67:181-188.
3. Linjakumpu T., Hartikainen S., Klaukka T., et al. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 2002, 55:809-817.
4. Gnjidic D., Cumming R.G., Le Couteur D.G., et al. Drug Burden Index and physical function in older Australian men. Br J Clin Pharmacol 2009, 68:97-105.
5. Wilson N.M., Hilmer S.N., March L.M., et al. Associations between Drug Burden Index and falls in older people in residential aged care. J Am Geriatr Soc 2011, 59:875-880.
6. Hilmer S.N., Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther 2009, 85:86-88.
7. Hajjar E.R., Cafiero A.C., Hanlon J.T. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007, 5:345-351.
8. Jorgensen T., Johansson S., Kennerfalk A., et al. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother 2001, 35:1004-1009.
9. Bjerrum L., Sogaard J., Hallas J., et al. Polypharmacy: correlations with sex, age and drug regimen. A prescription database study. Eur J Clin Pharmacol 1998, 54:197-202.
10. Crentsil V., Ricks M.O., Xue Q.L., et al. A pharmacoepidemiologic study of community-dwelling, disabled older women: factors associated with medication use. J Am Geriatr Soc 2010, 8:215-224.
11. Mallet L., Spinewine A., Huang A. The challenge of managing drug interactions in elderly people. Lancet 2007, 370:185-191.
12. Beer C., Loh P.K., Peng Y.G., et al. A pilot randomized controlled trial of deprescribing. Ther Adva Drug Saf 2011, 2:37-43.
13. Iyer S., Naganathan V., McLachlan A.J., et al. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging 2008, 25:1021-1031.
14. Loganathan M., Singh S., Franklin B.D., et al. Interventions to optimise prescribing in care homes: systematic review. Age Ageing 2011, 40:150-162.
15. Rollason V., Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging 2003, 20:817-832.
16. Verrue C.L., Petrovic M., Mehuys E., et al. Pharmacists' interventions for optimization of medication use in nursing homes: a systematic review. Drugs Aging 2009, 26:37-49.
17. Hughes C.M., Lapane K.L. Pharmacy interventions on prescribing in nursing homes: from evidence to practice. Ther Adva Drug Saf 2011, 1-10.
18. Gnjidic D., Le Couteur D.G., Abernethy D.R., et al. A pilot randomized clinical trial utilizing the drug burden index to reduce exposure to anticholinergic and sedative medications in older people. Ann Pharmacother 2010, 44:1725-1732.
19. Bain K.T., Holmes H.M., Beers M.H., et al. Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc 2008, 56:1946-1952.
20. Graves T., Hanlon J.T., Schmader K.E., et al. Adverse events after discontinuing medications in elderly outpatients. Arch Intern Med 1997, 157:2205-2210.
21. Gerety M.B., Cornell J.E., Plichta D.T., et al. Adverse events related to drugs and drug withdrawal in nursing home residents. J Am Geriatr Soc 1993, 41:1326-1332.
22. Le Couteur D.G., Banks E., Gnjidic D., et al. Deprescribing. Australian Prescriber 2011, 34:182-185.
23. MacLaughlin E.J., Raehl C.L., Treadway A.K., et al. Assessing medication adherence in the elderly: which tools to use in clinical practice?. Drugs Aging 2005, 22:231-255.
24. Rochon P.A., Gurwitz J.H. Optimising drug treatment for elderly people: the prescribing cascade. BMJ 1997, 315:1096-1099.
25. Hardy J.E., Hilmer S.N. Deprescribing in the last year of life. J Pharm Res 2011, 41.
26. Zarowitz B.J., Stebelsky L.A., Muma B.K., et al. Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting. Pharmacotherapy 2005, 25:1636-1645.
27. Tamai I.Y., Rubenstein L.Z., Josephson K.R., et al. Impact of computerized drug profiles and a consulting pharmacist on outpatient prescribing patterns: a clinical trial. Drug Intell Clin Pharm 1987, 21:890-895.
28. Britton M.L., Lurvey P.L. Impact of medication profile review on prescribing in a general medicine clinic. Am J Hosp Pharm 1991, 48:265-270.
29. Blakey S.A., Hixson-Wallace J.A. Clinical and economic effects of pharmacy services in geriatric ambulatory clinic. Pharmacotherapy 2000, 20:1198-1203.
30. Garfinkel D., Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med 2010, 170:1648-1654.
31. Fillit H.M., Futterman R., Orland B.I., et al. Polypharmacy management in Medicare managed care: changes in prescribing by primary care physicians resulting from a program promoting medication reviews. Am J Manag Care 1999, 5:587-594.
32. Tamura B.K., Bell C.L., Lubimir K., et al. Physician intervention for medication reduction in a nursing home: the polypharmacy outcomes project. J Am Med Dir Assoc 2011, 12:326-330.
33. Muir A.J., Sanders L.L., Wilkinson W.E., et al. Reducing medication regimen complexity: a controlled trial. J Gen Intern Med 2001, 16:77-82.
34. Thompson J.F., McGhan W.F., Ruffalo R.L., et al. Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. J Am Geriatr Soc 1984, 32:154-159.
35. King M.A., Roberts M.S. Multidisciplinary case conference reviews: improving outcomes for nursing home residents, carers and health professionals. Pharm World Sci 2001, 23:41-45.
36. Zermansky A.G., Petty D.R., Raynor D.K., et al. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001, 323:1340-1343.
37. Hanlon J.T., Weinberger M., Samsa G.P., et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996, 100:428-437.
38. Zermansky A.G., Alldred D.P., Petty D.R., et al. Clinical medication review by a pharmacist of elderly people living in care homes-randomised controlled trial. Age Ageing 2006, 35:586-591.
39. Furniss L., Burns A., Craig S.K., et al. Effects of a pharmacist's medication review in nursing homes. Randomised controlled trial. Br J Psychiatry 2000, 176:563-567.
40. Williams M.E., Pulliam C.C., Hunter R., et al. The short-term effect of interdisciplinary medication review on function and cost in ambulatory elderly people. J Am Geriatr Soc 2004, 52:93-98.
41. Kroenke K., Pinholt E.M. Reducing polypharmacy in the elderly. A controlled trial of physician feedback. J Am Geriatr Soc 1990, 38:31-36.
42. Meyer T.J., Van Kooten D., Marsh S., et al. Reduction of polypharmacy by feedback to clinicians. J Gen Intern Med 1991, 6:133-136.
43. Schmader K.E., Hanlon J.T., Pieper C.F., et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 2004, 116:394-401.
44. Allard J., Hebert R., Rioux M., et al. Efficacy of a clinical medication review on the number of potentially inappropriate prescriptions prescribed for community-dwelling elderly people. CMAJ 2001, 164:1291-1296.
45. Pitkala K.H., Strandberg T.E., Tilvis R.S. Is it possible to reduce polypharmacy in the elderly?. A randomised, controlled trial. Drugs Aging 2001, 18:143-149.
46. Avorn J., Soumerai S.B. Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing". N Engl J Med 1983, 308:1457-1463.
47. Lenaghan E., Holland R., Brooks A. Home-based medication review in a high risk elderly population in primary care-the POLYMED randomised controlled trial. Age Ageing 2007, 36:292-297.
48. Steele M.A., Bess D.T., Franse V.L., et al. Cost effectiveness of two interventions for reducing outpatient prescribing costs. DICP 1989, 23:497-500.
49. Lipton H.L., Bird J.A. The impact of clinical pharmacists' consultations on geriatric patients' compliance and medical care use: a randomized controlled trial. Gerontologist 1994, 34:307-315.
50. Owens N.J., Sherburne N.J., Silliman R.A., et al. The Senior Care Study. The optimal use of medications in acutely ill older patients. J Am Geriatr Soc 1990, 38:1082-1087.
51. Rubenstein L.Z., Josephson K., Wieland G.D., et al. Geriatric assessment on a subacute hospital ward. Clin Geriatr Med 1987, 3:131-143.
52. Pope G., Wall N., Peters C.M., et al. Specialist medication review does not benefit short-term outcomes and net costs in continuing-care patients. Age Ageing 2011, 40:307-312.
53. Roberts M.S., Stokes J.A., King M.A., et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol 2001, 51:257-265.
54. Schmidt I., Claesson C.B., Westerholm B., et al. The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J Am Geriatr Soc 1998, 46:77-82.
55. Weber V., White A., McIlvried R. An electronic medical record (EMR)-based intervention to reduce polypharmacy and falls in an ambulatory rural elderly population. J Gen Intern Med 2008, 23:399-404.
56. Kaushal R., Shojania K.G., Bates D.W. Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Intern Med 2003, 163:1409-1416.
57. Majumdar S.R., Soumerai S.B. Why most interventions to improve physician prescribing do not seem to work. CMAJ 2003, 169:30-31.
58. Wilson N., Gnjidic D., March L., et al. Use of PPIs are not associated with mortality in institutionalized older people. Arch Intern Med 2011, 171:866.
59. Gallagher P.F., O'Connor M.N., O'Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther 2011, 89:845-854.
60. Gnjidic D., Le Couteur D.G., Abernethy D.R., et al. Reducing drugs in older adults is more. Arch Intern Med 2011, 171:868-869.